Stenting for Intracranial Hypertension on Acetazolamide
Treatments studied
Part of Brain & nervous system, Ear, nose & throat clinical trials.
This trial tests whether placing a stent (a small tube) in a narrowed brain vein can help reduce pressure in the head in people with Intracranial Hypertension who have been on acetazolamide for over a year. It may be an option if you still have high pressure despite medication.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years or older.
- You must have a diagnosis of Idiopathic Intracranial Hypertension (IIH) that meets the modified Dandy criteria.
- You must have been taking acetazolamide (a medicine to lower pressure) for more than one year.
- An MRI must show narrowing of the main vein(s) draining the brain (transverse venous sinus stenosis).
- You cannot have taken topiramate in the past month.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether placing a small tube (stent) in a narrowed brain vein can help people with newly diagnosed intracranial hypertension (high pressure in the head) that causes vision problems. It is for those who have not yet taken standard medication and have specific vein narrowing seen on MRI.
This trial tests if a small tube called a stent can be placed in a vein in your brain to relieve high pressure. It may help people with headaches, vision changes, or other symptoms from this condition.
This trial tests a special expandable stent placed in narrowed veins in the brain to relieve high fluid pressure in the brain and spinal cord. It may help reduce headaches, vision problems, and ear ringing caused by this condition.
This study uses advanced brain scans (MRIs) to look at the veins in your brain to help plan a stenting procedure for patients with Idiopathic Intracranial Hypertension (IIH) that is not improving with standard care.
This trial tests if tirzepatide can help lower the pressure inside your skull caused by a condition called Idiopathic Intracranial Hypertension. It's designed for people with a BMI of 30 or higher who have swelling of the optic nerve.
This trial tests whether eptinezumab, a medication that reduces a brain chemical called CGRP (involved in migraines), can help reduce headaches in people with idiopathic intracranial hypertension (IIH)—a condition where pressure builds up around the brain. The study wants to see if this treatment safely reduces headache frequency and severity.
Hear when a new Idiopathic Intracranial Hypertension (IIH) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.